Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations.

The article focuses on Dana-Farber Cancer Institute's actions to retract at least six research papers and correct 31 others following allegations of data manipulation, including papers authored by high-ranking officials on topics such as multiple myeloma and immune cells. Topics include the investigation sparked by a blog post highlighting image manipulation and errors in nearly 60 papers published between 1997 and 2017, and the specific irregularities noted by the blogger.